NASDAQ:ADUS - Addus Homecare Stock Price, Forecast & News

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Addus Homecare Co. (NASDAQ:ADUS) announced its quarterly earnings results on Monday, November, 4th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.13. The company had revenue of $169.80 million for the quarter, compared to analyst estimates of $160.25 million. Addus Homecare had a net margin of 3.35% and a return on equity of 8.00%. Addus Homecare's revenue for the quarter was up 23.3% compared to the same quarter last year. View Addus Homecare's Earnings History.

Addus Homecare is scheduled to release their next quarterly earnings announcement on Monday, March 2nd 2020. View Earnings Estimates for Addus Homecare.

8 analysts have issued 1 year price targets for Addus Homecare's stock. Their forecasts range from $75.00 to $115.00. On average, they expect Addus Homecare's share price to reach $96.29 in the next twelve months. This suggests that the stock has a possible downside of 1.8%. View Analyst Price Targets for Addus Homecare.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Addus Homecare.

Press coverage about ADUS stock has trended somewhat negative recently, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Addus Homecare earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Addus Homecare.

Some companies that are related to Addus Homecare include Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), BioScrip (BIOS) and New York Health Care (BBAL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include AbbVie (ABBV), Align Technology (ALGN), Activision Blizzard (ATVI), Gilead Sciences (GILD), Energy Transfer LP Unit (ET), IBM (IBM), Pfizer (PFE), AT&T (T), Exxon Mobil (XOM) and Celgene (CELG).

Addus Homecare's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.53%), California Public Employees Retirement System (0.25%), Columbus Circle Investors (0.13%), Virginia Retirement Systems ET AL (0.11%), Bridge City Capital LLC (0.11%) and Sheets Smith Wealth Management (0.08%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Institutional Ownership Trends for Addus Homecare.

ADUS stock was sold by a variety of institutional investors in the last quarter, including Virginia Retirement Systems ET AL, SG Americas Securities LLC, Arizona State Retirement System, Calamos Advisors LLC, Eqis Capital Management Inc. and Louisiana State Employees Retirement System. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Insider Buying and Selling for Addus Homecare.

ADUS stock was bought by a variety of institutional investors in the last quarter, including Bridge City Capital LLC, California Public Employees Retirement System, Columbus Circle Investors, Sheets Smith Wealth Management, Miles Capital Inc., Zurcher Kantonalbank Zurich Cantonalbank and State of Alaska Department of Revenue. View Insider Buying and Selling for Addus Homecare.

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ADUS stock can currently be purchased for approximately $98.09.

Addus Homecare has a market capitalization of $1.53 billion and generates $518.12 million in revenue each year. The company earns $17.50 million in net income (profit) each year or $1.69 on an earnings per share basis. Addus Homecare employs 33,153 workers across the globe.View Additional Information About Addus Homecare.

The official website for Addus Homecare is http://www.addus.com/.

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]